A study carried out by the Center for Political Economy (CEPA) also warns of the impact of the exclusion of 44 remedies from the 100% coverage of the PAMI.
The medications most used by older adults had a cumulative increase of 202% since the arrival of Javier Milei to the governmentaccording to a report from the Center for Political Economy (CEPA) carried out in conjunction with the Center for Political Studies for Older Persons (CEPPEMA) and the Latin American Association of Community Gerontology (ALGEC).
The content you want to access is exclusive to subscribers.
The survey specifies that the main medications used by older adults increased by 25.7% at the end of November, in December 40.9%, in January 13.6%, in February 15.0%, in March 8.4 %, in April 2.5%, in May 3.8%, in June 2.8%, in July 5.0%, in August 3.0% and in September 1.7%. “In 11 months, Medications that older people regularly use have registered an accumulated inflation of 202.0%“, it was indicated.


In turn, the 10 remedies that increased the most registered an average year-on-year increase of 282%. Among these products are DAFLON 500, which is a venotonic used to increase the tone of the veins and also a vasculoprotector used to increase the resistance of small blood vessels, which increased 331%, and IBUPIRAC 600 MG, which is one of the non-inflammatory anti-inflammatories. steroid (NSAID) most used to combat pain and fever, which increased 316%.
Another point that the study points out is that in August 2024, PAMI reduced 44 medications that had 100% coverage in its formulary. “In June another 11 molecules had been reduced. For this reason, the increases in 7.9% and 4.9% for the months of August and September respectively are given on a reduced basket of PAMI medications. If we look at the basket of medicines surveyed in previous months, the figure for the month of August reaches 24.4% increase and September 9.7%“.
Regarding medicines excluded from the basket PAMI, It is observed that the three that registered the greatest increases in their prices between August and September 2024 were: lanzopral, with an increase of 71.7%, Dermaglós, with a rise of 70.8% and Acimed, whose price increased by 66.7%.
“The reduction of pharmacological molecules implies that Now a third fewer medications are offered compared to those that were distributed for free before Javier Milei’s administration.“, is noted in the study.
The price of medicines increases: a strong blow to the pockets of retirees
In this sense, it warns that the reduction of coverage by PAMI and the sharp increase in prices directly affects retirees, since it directly impacts the cost of living. “by forcing them to face greater expenses in the purchase of medicines.”
“Until July, the comprehensive free and discounted drug program has allowed for average savings of $63,800. Of every 10 members, 4 receive all their medications for free, 5 in 10 get at least two medications at no cost and 9 in 10 get at least one“adds the report.
“Without a doubt, this loss of indirect income that represented the granting of a greater amount of medication at no cost and the non-updating of the bonuses that compensate the retirement mobility formula, imply a serious setback in terms of rights and quality of life of older people,” concludes the study.
Source: Ambito

I am Pierce Boyd, a driven and ambitious professional working in the news industry. I have been writing for 24 Hours Worlds for over five years, specializing in sports section coverage. During my tenure at the publication, I have built an impressive portfolio of articles that has earned me a reputation as an experienced journalist and content creator.